GINGER OSBORNE: Open Payments
NPI 1477085587 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 8 companies in 2025. Trend: 2023 $376 · 2024 $306 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Travere Therapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Teleflex LLC | 1 | $15 |
| MicroTransponder, Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Wegovy, Kerendia, HYQVIA, TRELEGY ELLIPTA, UROLIFT, JARDIANCE.
Industry payments across KY — which companies pay providers there.
